Acquired Thrombotic Thrombocytopenic Purpura (TTP) Presenting With Synthetic Cannabinoid Use. [PDF]
Douglass MB +4 more
europepmc +1 more source
Metabolic profiling of the synthetic cannabinoid APP-CHMINACA (PX-3) as studied by in vitro and in vivo models. [PDF]
Camuto C +6 more
europepmc +1 more source
The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB<sub>2</sub> receptor activation. [PDF]
Reck AM, Siderovski DP, Kinsey SG.
europepmc +1 more source
Evaluation of the metabolic activity, angiogenic impacts, and GSK-3β signaling of the synthetic cannabinoid MMB-2201 on human cerebral microvascular endothelial cells. [PDF]
Al-Eitan LN +6 more
europepmc +1 more source
Pharmacological evaluation of new generation OXIZID synthetic cannabinoid receptor agonists. [PDF]
Patel M +6 more
europepmc +1 more source
Screening and Quantification of the Synthetic Cannabinoid Receptor Agonist 5F-MDMB-PINACA From Seized Prison Paper Using Ultraperformance Liquid Chromatography-Mass Spectrometry Approaches. [PDF]
Vaccaro G +4 more
europepmc +1 more source
The biological effects and thermal degradation of NPB-22, a synthetic cannabinoid. [PDF]
Takeda A +13 more
europepmc +1 more source
JWH-182: a safe and effective synthetic cannabinoid for chemotherapy-induced neuropathic pain in preclinical models. [PDF]
Filipiuc LE +16 more
europepmc +1 more source
Synthesis, Analytical Characterization, and Human CB<sub>1</sub> Receptor Binding Studies of the Chloroindole Analogues of the Synthetic Cannabinoid MDMB-CHMICA. [PDF]
Münster-Müller S +9 more
europepmc +1 more source
Related searches:
Biased agonism at the cannabinoid receptors – Evidence from synthetic cannabinoid receptor agonists
Cellular Signalling, 2021Mónica Patel +2 more
exaly

